loaderimg
image

Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018.
The Company’s self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration (“NMPA”) and commercialized in China.

Company’s Keywords:

Q How Many Employees Does This Company Have?

<39

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<65247000

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2009

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image